CEO of growing Peninsula biotech steps down in wake of FDA approval, big Pfizer deal

The sudden CEO switch comes as the company preps for the launch of its prostate cancer drug, seeks FDA approval of a treatment for heavy menstrual bleeding and looks to cut deals to beef up its drug portfolio.

Click to view original post